PL2912054T3 - Polipeptyd wiążący albuminę - Google Patents

Polipeptyd wiążący albuminę

Info

Publication number
PL2912054T3
PL2912054T3 PL13783052T PL13783052T PL2912054T3 PL 2912054 T3 PL2912054 T3 PL 2912054T3 PL 13783052 T PL13783052 T PL 13783052T PL 13783052 T PL13783052 T PL 13783052T PL 2912054 T3 PL2912054 T3 PL 2912054T3
Authority
PL
Poland
Prior art keywords
binding polypeptide
albumin binding
albumin
polypeptide
binding
Prior art date
Application number
PL13783052T
Other languages
English (en)
Inventor
Per Jonasson
Pär Eklund
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody Ab filed Critical Affibody Ab
Publication of PL2912054T3 publication Critical patent/PL2912054T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
PL13783052T 2012-10-25 2013-10-25 Polipeptyd wiążący albuminę PL2912054T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718238P 2012-10-25 2012-10-25
EP12189932 2012-10-25
EP13783052.7A EP2912054B1 (en) 2012-10-25 2013-10-25 Albumin binding polypeptide

Publications (1)

Publication Number Publication Date
PL2912054T3 true PL2912054T3 (pl) 2017-11-30

Family

ID=47115503

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13783052T PL2912054T3 (pl) 2012-10-25 2013-10-25 Polipeptyd wiążący albuminę

Country Status (11)

Country Link
US (1) US10011641B2 (pl)
EP (1) EP2912054B1 (pl)
JP (1) JP6382826B2 (pl)
KR (1) KR102151289B1 (pl)
CN (1) CN104854127B (pl)
AU (1) AU2013336646B2 (pl)
CA (1) CA2889037C (pl)
DK (1) DK2912054T3 (pl)
ES (1) ES2639099T3 (pl)
PL (1) PL2912054T3 (pl)
WO (1) WO2014064237A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1218534A1 (zh) * 2013-03-14 2017-02-24 多伦多大学管理委员会 支架化肽文库以及其制备和筛选方法
EP2970406B1 (en) 2013-03-15 2017-12-13 Affibody AB New polypeptides
US10633423B2 (en) 2014-06-13 2020-04-28 Affibody Ab IL-6-binding polypeptide complex
CN106488930B (zh) * 2014-06-13 2021-11-02 阿菲博迪公司 新型多肽
US10323066B2 (en) 2014-09-17 2019-06-18 Affibody Ab Neonatal Fc receptor binding dimer and methods of use
PT3245224T (pt) * 2015-01-12 2020-10-08 Affibody Ab Polipéptidos de ligação a il-17a
UY37651A (es) * 2017-03-31 2018-10-31 Swedish Orphan Biovitrum Ab Publ Polipéptido de unión al il-1r-i
WO2019126364A2 (en) * 2017-12-19 2019-06-27 The Scripps Research Institute Compositions and methods related to nicotine addiction and cessation
WO2019175176A1 (en) 2018-03-13 2019-09-19 Affibody Ab Polypeptides based on a novel scaffold
CN109776653B (zh) * 2018-11-26 2022-05-17 上海华新生物高技术有限公司 一种人血清白蛋白黏附肽及其应用
EP3785726A1 (en) 2019-09-02 2021-03-03 Biotest AG Factor viii protein with increased half-life
EP4017521A1 (en) 2019-09-02 2022-06-29 Biotest AG Factor viii protein with increased half-life

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7608681B2 (en) 1999-12-24 2009-10-27 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US8937153B2 (en) * 2007-07-31 2015-01-20 Affibody Ab Compositions, methods and uses
US8426557B2 (en) 2007-08-03 2013-04-23 Affibody Ab IGF-1R binding polypeptides and their use
EP2077272A1 (en) * 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
ATE527353T1 (de) 2007-12-19 2011-10-15 Affibody Ab Pdgf-bindendes polypeptid aus protein a
CA2739352C (en) 2008-10-29 2021-07-13 Wyeth Llc Methods for purification of single domain antigen binding molecules
EP2496598B1 (en) 2009-11-04 2017-08-02 Affibody AB Her3 binding polypeptides
NZ604805A (en) 2010-07-09 2014-09-26 Affibody Ab Polypeptides
RS58503B1 (sr) * 2012-02-20 2019-04-30 Swedish Orphan Biovitrum Ab Publ Polipeptidi koji se vezuju za humani komplement c5
EP2912051B1 (en) 2012-10-25 2018-04-18 Affibody AB Method for the separation of proteins containing an albumin-binding domain

Also Published As

Publication number Publication date
CN104854127A (zh) 2015-08-19
US20150291668A1 (en) 2015-10-15
KR102151289B1 (ko) 2020-09-02
JP2015534994A (ja) 2015-12-07
CA2889037C (en) 2021-06-22
JP6382826B2 (ja) 2018-08-29
US10011641B2 (en) 2018-07-03
ES2639099T3 (es) 2017-10-25
HK1210793A1 (en) 2016-05-06
WO2014064237A1 (en) 2014-05-01
AU2013336646A1 (en) 2015-05-28
KR20150077447A (ko) 2015-07-07
EP2912054B1 (en) 2017-06-21
CA2889037A1 (en) 2014-05-01
AU2013336646B2 (en) 2016-07-14
EP2912054A1 (en) 2015-09-02
DK2912054T3 (en) 2017-09-11
CN104854127B (zh) 2020-12-25

Similar Documents

Publication Publication Date Title
IL291571A (en) cx3cr1 binding polypeptides
IL254652B (en) Unnatural albumin binding sites
IL235093A0 (en) 3cd binding polypeptides
IL238185A0 (en) Albumin variants
IL233689A0 (en) Albumin variants
IL240838A0 (en) Anti-3–lag binding proteins
ZA201504478B (en) Immunotherapy with binding agents
SI2822577T1 (sl) Rekombinantni proteini faktorja VIII
GB201220474D0 (en) Polypeptides
SG11201403769YA (en) Nucleic acids specifically binding cgrp
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201204868D0 (en) Peptides
GB201418608D0 (en) Peridinin-chlorophyll binding proteins
GB201213672D0 (en) Protein
GB201203944D0 (en) Binding polypeptides
SG11201504096RA (en) Recombinant protein
GB201204065D0 (en) Fusion polypeptide
GB201214293D0 (en) Binding surfaces
GB201210286D0 (en) Recombinant polypeptide
GB201211503D0 (en) Heparin binding peptides
GB201103961D0 (en) Binding polypeptides
GB201200743D0 (en) Protein bridges
GB201215901D0 (en) Protein modification
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides